KnowledgeBase

• Home
• Antimicrobials
• Microorganisms
• About Us
• Contact Us

• Search All
• Search by Antimicrobial
• Search by Microorganism
• 

Home › Search by Microorganism › Lactobacillus fermentum (BL10 + novobiocin-resistant + clindamycin-resistant + tetracycline-resistant)

• Lactobacillus fermentum
• Lactobacillus fermentum (BL10 + novobiocin-resistant + clindamycin-resistant + tetracycline-resistant)
• Lactobacillus fermentum (Bu6 + streptomycin-resistant + tobramycin-resistant + tetracycline-resistant)
• Lactobacillus fermentum (ciprofloxacin-resistant + tetracycline-resistant)
• Lactobacillus fermentum (E2 + erm(LF))
• Lactobacillus fermentum (Etest)
• Lactobacillus fermentum (F 12 + Greece)
• Lactobacillus fermentum (JCM 1173)
• Lactobacillus fermentum (LCF7 + erm(LF) + tobramycin-resistant)
• Lactobacillus fermentum (P59 + tetracycline-resistant)
• Lactobacillus fermentum (PLV10 + tobramycin-resistant + erm(LF))
• Lactobacillus fermentum (R1 + novobiocin-resistant + tetracycline-resistant)
• Lactobacillus fermentum (ROT1 + novobiocin-resistant + tet(M))

This project is supported by TOKU-E which specializes in manufacturing ultra-pure antibiotics for a broad spectrum of biotechnology applications as well as for the pharmaceutical industry. TOKU-E is a global leader in biotechnology innovation, offering great benefits and applications to the biopharmaceutical and diagnostic industries as well as for biotechnology research communities.
Privacy Policy | Terms of Use
Knowledgebase version 1.8